Navigation Links
Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
Date:12/15/2008

pathway that can be inhibited by SYI-2074.

About Psoriasis

Psoriasis is an immune-mediated chronic inflammatory disease usually characterized by red lesions or silvery white scales on the skin, which usually occur on the scalp, knees, elbows, the abdomen (around the navel) and the genitals. In about a quarter of the cases, psoriasis can lead to psoriatic arthritis, another inflammatory disease affecting the joints.

While the exact cause of the disease is unknown, it is believed that both genetic and hormonal factors play a role. It is also known that the TNF-alpha pathway plays a role in the progression of the disease. Other companies have successfully developed drugs that also interfere with TNF-alpha signaling, but these similar drugs are given as injections and are indicated for more severe forms of the disease. Synvista intends to differentiate SYI-2074 by developing a topical formulation of the drug for the treatment of mild-to-moderate psoriasis.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing diagnostics and drugs to diagnose, treat and prevent cardiovascular disease in people with diabetes. The Company has developed a clinical laboratory test that identifies diabetic patients with the Haptoglobin genotype Hp2-2. The genetic or protein form of this test can be used to identify diabetic patients at high risk for cardiovascular complications. These patients may benefit from a particular formulation of vitamin E. The Company is also developing a test kit to measure CML (carboxy-methyllysine), another potential cardiovascular risk marker.

Synvista Therapeutics is developing oral antioxidant drugs to treat the HDL dysfunction seen in Hp2-2 diabetes, a disease affecting almost 7 million patients in the United States. The Company is also developing alagebrium, a proposed breaker of advanced glyca
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
2. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
3. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
4. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
5. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
6. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
7. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
8. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
9. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 Depomed, Inc. (NASDAQ: DEPO ) today ... th Annual Healthcare Conference in New York City ... is scheduled for 8:00 am EST (5:00 am PST) on Tuesday ... can be accessed via the Investor Relations page of the Depomed ... be archived for 30 days on the company,s website. ...
(Date:11/21/2014)... Nov. 20, 2014   Wellcentive , the ... for healthcare organizations, announced today being named one ... Intel Innovation Award .  Sponsored by Intel, the ... its fourth year, recognizes companies developing leading-edge technology ... delivery processes. Wellcentive,s Mason ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
Breaking Medicine Technology:Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
(Date:11/22/2014)... Forbes Living TV and featured ... that Ashley Lombardo and friend Candy Sherman are the ... Lombardo entered friend Candy Sherman to receive a generous ... her friend is courageously battling lung cancer and raising ... medical bills piling up and the constant struggle to ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 A ... was announced today which safely detects and identifies ... frequency radio waves. Developed by RHT SpectraSafe, the ... hosts broad applications in other areas including medical, ... security. , Using high frequency radio waves that ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
(Date:11/22/2014)... News) -- Many young people consider hookahs a hip ... finds fumes from the water pipes contain the toxin ... risk for leukemia in prior research, according to a ... Cancer Epidemiology, Biomarkers & Prevention . "In contrast ... a safe alternative to smoking other forms of tobacco," ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3
... a link between air pollution and heart attacks. ... and Haemostasis looks specifically at airborne particulate matter ... coal and also from forest fires, reports science ... and long-term exposure to these particulates is associated ...
... already a huge health problem in Asia that is getting ... years (by 2050), one out of every two fractures in ... figures projected above, it would be sensible for men and ... of their lifestyle. ,Osteoporosis, in which the bones ...
... a study in the September issue of Archives of ... for poor health and mental conditions//. ,Besides basic ... and understand numerical information such as that on prescription ... information such as appointment slips, to be able to ...
... face more than twice the risk of developing breast ... Netherlands examined the relation between handedness// and incidence of ... born between 1932 and 1941, reports science portal EurekAlert. ... such as social and economic status, smoking habits, family ...
... presenting a paper at the 109th Annual Meeting & ... held September 25-28, 2005 on the impact of age ... adult patients with inflammatory paranasal sinus disease at a ... disease is used to encompass CRS, CRS with polyposis, ...
... in the plant kingdom among pulses. Besides providing the body ... to have numerous other health benefits//. It is nicknamed as ... of diabetes, and improve overall health. ,Sometime back ... the Post menopausal period but now men have a reason ...
Cached Medicine News:Health News:Beauty Queens Urge On The Importance Of Maintaining Bone Integrity 2Health News:Age Can Changes Symptoms Of Sinusitis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: